REDUCED VERAPAMIL CLEARANCE DURING LONG-TERM ORAL-ADMINISTRATION

被引：140

作者：

SHAND, DG ^{[1
]}

HAMMILL, SC ^{[1
]}

AANONSEN, L ^{[1
]}

PRITCHETT, ELC ^{[1
]}

机构：

[1] DUKE UNIV,MED CTR,DIV CARDIOL,DURHAM,NC 27710

来源：

关键词：

D O I：

10.1038/clpt.1981.223

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：701 / 703

页数：3

共 6 条

[1] EVANS GH, 1973, CLIN PHARMACOL THER, V14, P487
[2] HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF VERAPAMIL .2. SIMULTANEOUS QUANTITATION OF VERAPAMIL AND ITS ACTIVE METABOLITE, NORVERAPAMIL
HARAPAT, SR
KATES, RE
[J]. JOURNAL OF CHROMATOGRAPHY, 1980, 181 (3-4): : 484 - 489
[3] ROUTLEDGE PA, 1980, APPLIED PHARM
[4] PHYSIOLOGICAL DISPOSITION OF VERAPAMIL IN MAN
SCHOMERUS, M
SPIEGELHALDER, B
STIEREN, B
EICHELBAUM, M
[J]. CARDIOVASCULAR RESEARCH, 1976, 10 (05) : 605 - 612
[5] 4-HYDROXYPROPRANOLOL AND ITS GLUCURONIDE AFTER SINGLE AND LONG-TERM DOSES OF PROPRANOLOL
WALLE, T
CONRADI, EC
WALLE, UK
FAGAN, TC
GAFFNEY, TE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (01) : 22 - 31
[6] WILKINSON GR, 1975, CLIN PHARMACOL THER, V18, P377